A trial looking at camizestrant for early breast cancer (CAMBRIA-1)
This trial is looking at a new drug called camizestrant for early breast cancer that has a medium to high risk of coming back.
This trial is looking at a new drug called camizestrant for early breast cancer that has a medium to high risk of coming back.
This trial is comparing a combination of 2 chemotherapy drugs with a combination of 3 chemotherapy drugs for bowel cancer.
This trial is looking at chemotherapy before surgery for bowel cancer to improve treatment.
This study is looking at the tests and treatment people with breast cancer have when it has come back in the same breast or nearby area.
This trial is looking at the need to treat the lymph glands in the armpit after having chemotherapy followed by surgery for breast cancer.
This study looked at the products women buy to help manage symptoms that could be a sign of ovarian cancer.
This trial is looking at adding hydroxychloroquine to chemotherapy for people with small cell lung cancer that has spread.
This study is to see if women who only have a very small risk of their breast cancer returning need to have radiotherapy after surgery.
This study is looking at a tool called Caris Molecular Intelligence (CMI).
This study is looking at using circulating tumour cells to try and diagnose pancreatic cancer early.